Evaluating the impact of guidelines on urinary tract infections related to ureteral stents
Ureteral Stent Exchange Abstention in Urinary Tract Infections: a Before-and-after Study to Assess Guidelines' Impact on Patients' Outcomes
Central Hospital, Nancy, France · NCT06503588
This study is testing if following new guidelines for treating urinary tract infections in patients with ureteral stents helps reduce the chances of getting infections again.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 300 (estimated) |
| Sex | All |
| Sponsor | Central Hospital, Nancy, France (other) |
| Locations | 1 site (Nancy, Lorraine) |
| Trial ID | NCT06503588 on ClinicalTrials.gov |
What this trial studies
This observational study assesses the effectiveness of newly established guidelines for managing urinary tract infections (UTIs) associated with ureteral stents. It compares the occurrence of relapse or recurrence of UTIs in patients treated after the implementation of these guidelines to those treated before. The study focuses on patients with indwelling ureteral catheters who have confirmed or probable UTIs, aiming to determine if adherence to the guidelines leads to improved patient outcomes. The approach emphasizes surgical abstention as a potential intervention.
Who should consider this trial
Good fit: Ideal candidates for this study are patients with indwelling ureteral catheters who have confirmed or probable urinary tract infections.
Not a fit: Patients who may not benefit from this study include those who oppose participation, have a history of ileal conduit urinary diversion, or experience multiple urinary tract infections during the study period.
Why it matters
Potential benefit: If successful, this study could lead to improved management strategies for patients with urinary tract infections related to ureteral stents.
How similar studies have performed: While this study is based on newly established guidelines, similar approaches in managing urinary tract infections have shown promise, though this specific evaluation is novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * All patients with indwelling ureteral catheter * AND confirmed or probable urinary tract infection Exclusion Criteria: * Patient's opposition * History of ileal conduit urinary diversion * Second or more urinary tract infection during the study period
Where this trial is running
Nancy, Lorraine
- Nancy university hospital — Nancy, Lorraine, France (RECRUITING)
Study contacts
- Principal investigator: +33383154097 Lefevre, M.D. PhD — Central Hospital, Nancy, France
- Study coordinator: Benjamin Lefevre, M.D. PhD
- Email: b.lefevre@chru-nancy.fr
- Phone: +33383154097
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Urinary Tract Infections, Urinary Catheterization